Natroba Suspension
Product Images NDC 84635-929

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Natroba (NDC 84635-929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipher Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Natroba 01)

FDA Label Image

Chemical Structure (Natroba 02)

FDA Label Image

Image (Natroba 03)

FDA Label Image

Image (Natroba 04)

FDA Label Image

Image (Natroba 05)

FDA Label Image

Image (Natroba 06)

FDA Label Image

Image (Natroba 07)

FDA Label Image

Image (Natroba 08)

FDA Label Image

Figure A (Natroba 09)

FDA Label Image

Figure B (Natroba 10)

FDA Label Image

Figure C (Natroba 11)

FDA Label Image

Figure D (Natroba 12)

FDA Label Image

Figure E (Natroba 13)

FDA Label Image

Figure F (Natroba 14)

FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
This is a set of directions for using Natroba topical suspension, a medication containing spinosad for treating lice infestations. It includes warnings to keep the product out of reach of children, avoid contact with eyes, and not to swallow the product. It also advises seeking medical attention if irritation or infection occurs after use. The instructions emphasize shaking the product well before use and highlight that it is for topical use only. The product is available in a 120mL size.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.